fbpx
Select Page

Testing for COVID-19 antibodies may be the most important part of getting accurate data about how many people have actually been exposed. Recent tests of sample population in California indicate the number asymptomatic and mildy symptomatic undetected cases could increase the number of people exposed to the virus by 50 – 80 fold (see link below).

“The cornerstone in the front-line battle against the virus is our body forming antibodies.”

Mark Abdelmalek, MD

Dr. Abdelmalek indicated that in addition to the data needed to help public health officials set disease management strategies, it also answers these important questions:

      1.  Did I have it, and did my immune system mount a response?
      2.  Can I be a ‘super donor’ to help treat sick patients?

“In an ideal world, we should be doing both antibody and virus tests at the same time.1 The more people that can get an antibody test, and we can see the results, the better idea we will know how many people had the virus.” 

  1. The (SARS CoV-2 IgM/IgG (COVID-19) Antibody Rapid Test Kits (Colloidal Gold) that Medformance will introduce in May 2020 tests for RNA (Pos/Neg) and lgM/lgG (Antibodies).